Abstract. Regulating the blood glucose level is a challenging control problem for the human body. Abnormal blood glucose levels can cause serious health problems over time, including diabetes. Although several mathematical models have been proposed to describe the dynamics of glucose-insulin interaction, none of them have been universally adopted by the research community. In this paper, we consider a dynamic model of the blood glucose regulatory system originally proposed by Liu and Tang in 2008. This model consists of eight state variables naturally divided into three subsystems: the glucagon and insulin transition subsystem, the receptor binding subsystem and the glucose subsystem. The model contains 36 model parameters, many of which are unknown and difficult to determine accurately. We formulate an optimal parameter selection problem in which optimal values for the model parameters must be selected so that the resulting model best fits given experimental data. We demonstrate that this optimal parameter selection problem can be solved readily using the optimal control software MISER 3.3. Using this approach, significant improvements can be made in matching the model to the experimental data. We also investigate the sensitivity of the resulting optimized model with respect to the insulin release rate. Finally, we use MISER 3.3 to determine optimal open loop controls for the optimized model.
1.
Introduction. Blood glucose is crucial to maintaining health. The normal concentration of blood glucose in a healthy person is between 80 to 120 (mg/dl); concentrations beyond this range may cause hyperglycaemia (above 120) or hypoglycaemia (under 80). Prolonged irregularities in the blood glucose level can result in major health problems such as diabetes, an incurable disease caused when the pancreas no longer makes insulin (type 1 diabetes), or when the pancreas cannot make enough insulin and the body develops insulin resistance (type 2 diabetes). Diabetes is considered a major international health problem. Approximately 3.61 million Australians have diabetes or pre-diabetes, and 366 million people have diabetes worldwide [3] .
To date, several mathematical models for the blood glucose regulatory system have been proposed. These models aim to describe the glucose-insulin interaction within the human body. The Bergman minimal model (1980) is considered to be the fundamental model in this area [1] . Several control models, such as proportionalintegral-derivative (PID) control [10] , robust servo control [6] , and model predictive 2 ZAHRA AL HELAL, VOLKER REHBOCK AND RYAN LOXTON control (MPC) [2] , have been developed based on the Bergman minimal model. In most of the existing models, the glucose regulatory system is greatly simplified and only glucose and insulin are considered.
Liu and Tang [8] have developed a new feedback control model at the molecular level, which considers the role of the liver, the glucagon and insulin signaling pathways and the conversion between glucose and glycogen. However, one of the difficulties in working with this model is that it contains many model parameters that are not well-defined. Thus, in this paper, we formulate an optimal parameter selection problem that can be solved using the software package MISER 3.3 [4] . As we will see, this approach results in significant improvements in matching the model to experimental data. This paper is organized as follows. We first introduce the dynamic model of blood glucose levels proposed in [8] in Section 2. Then, in Section 3, we formulate an optimal parameter selection problem to determine optimal values for the uncertain model parameters in the dynamic model. The objective here is to match the model to given experimental data as closely as possible. For this purpose, we consider three possible objective functions and solve the resulting problems using MISER 3.3. In Section 4, we perform a sensitivity test, as proposed in Liu and Tang [8] , on the resulting optimized model to test its sensitivity with respect to the insulin release rate. In Section 5, based on the optimized model, we formulate an optimal control problem in which the aim is to optimize the release rate for both insulin and glucose. This optimal control problem can also be solved using MISER 3.3. Finally, we conclude the paper with a discussion of the numerical results and future work. The model can be naturally divided into three subsystems, each of which is described below. See Figure 1 for a graphical representation.
2.1. Insulin and glucagon transition subsystem. This subsystem governs x 1 and x 2 . The model assumes that plasma insulin does not act directly on the glucose metabolism, but instead through remote cellular insulin. The model also assumes that intracellular insulin does not move back to plasma. Under these assumptions, the dynamics for x 1 are given by
where k p 1,1 is a transition rate, k p 1,2 is a degradation rate, and w 1 is the glucagon release rate (GRR) defined by Figure 1 . A simplified model of the regulatory system for blood glucose (adapted from reference [8] ). Glucose is input from food and the liver, and used by brain and nerve cells (insulinindependent, solid arrow) and by tissue cells (insulin-dependent, dashed arrow). Glucose is transported to and from liver cells by the concentration-driven GLUT2, which is insulin-independent. In response to low blood glucose levels, the α cells of the pancreas produce the hormone glucagon. The glucagon initiates a series of activations of kinases (the black arrows indicate such activations), and which ultimately leads to the activation of the enzyme glycogen phosphorylase, to catalyze the breakdown of glycogen into glucose. In response to high blood glucose levels, the β cells of the pancreas secrete insulin. Insulin triggers reactions to activate glycogen synthase, which catalyses the conversion of glucose into glycogen.
Furthermore, the dynamics for x 2 are given by 
The fractions w 1 and w 2 in equations (1)- (4) 
where k 2.3. Glucose production and utilization subsystem. This subsystem, which governs x 7 and x 8 , models the production of glucose. Plasma glucose has two sources: hepatic glucose produced by converting glycogen into glucose in the liver and exogenous glucose taken from food. Glucose utilization can be classified into two classes: insulin-independent (by brain and nerve cells) and insulin-dependent (by the muscle and fat cells). The dynamics for x 7 are given by
where
Here, k 1 , k 2 and k 3 are the feedback control gains, V 
Note that U 0 , U b , U m , C 2 , C 3 , C 4 and β are positive constants, and G is the exogenous glucose intake derived from digesting food.
Initial conditions and model constants.
We assume that the system is modelled over a 9 hour period, i.e., t ∈ [0, 540], where t is the time in minutes. The initial conditions prescribed for the model in Liu and Tang [8] are
The complete model defined by equations (1)-(23) includes 36 model constants as listed in Table 1 . Although Liu and Tang [8] give explicit values for each of these constants, they also acknowledge that many of these values are merely informed guesses, usually based on biological understanding or adopted from other publications. In Table 1 , we have indicated which of the constants are well-defined and which have some uncertainty as to their true values. Note that the values of some of the constants in Table 1 differ from the original values given by Liu and Tang in [8] . These changes were made based on the advice received in private communication with Liu and Tang. In particular, we have changed the units of measurement for the parameters k Table 1 and used throughout this paper. In addition, Liu and Tang gave the following guidance on the behaviour of some of the uncertain parameters: the degradation rates of glucagon and its receptor (k s 1,2 , k r 1 ) can be assumed to be the same as the respective rates for insulin (k s 2,2 , k r 2 ); the maximum glucagon infusion rate G m can be selected to be much smaller than R m ; a 1 and b 1 can be selected so that the glucagon secretion w 1 increases rapidly when the blood glucose level x 8 drops to around 800 mg/l; k p 2,1 can be assumed to be the same as k 3. Parameter estimation. Our goal in this paper is to optimize the model parameters in (1)- (23), so that the model matches experimental data as closely as possible. As in Liu and Tang [8] , we use the experimental data reported in Korach-André et al. [5] . This data set consists of blood glucose measurements from a healthy individual taken after meals. We denote this data set by {(τ i ,x
, where τ i denotes the i-th observation time andx 
Constant
Value Table 2 . Experimental data from Korach-André et al. [5] at the i-th observation time. The experimental data is shown in Figure 2 and listed in Table 2 . We assume that the experimental data can be interpolated linearly as shown in Figure 2 to yield the function g exp (t). Using the original parameter values in Liu and Tang [8] , the resulting trajectory for the blood glucose history is shown in Figure 3 . We will improve the Liu-Tang model by formulating an optimal parameter selection problem to find more appropriate values for the uncertain model parameters in Table 1 . To do this, for each uncertain parameter, we need to specify upper and lower bounds. For parameters V , U b , U 0 and β, appropriate bounds were suggested by Liu and Tang [8] in our personal correspondence as shown in Table 3 . For the other parameters, we use an iterative approach as follows. We initially guessed the lower and upper bounds and solved the resulting parameter estimation problem. Then, for those parameters whose optimal value was equal to the lower or upper bound, we decreased/increased the respective bound by 10 percent. This process continued until all optimal parameter values were contained in the interior of the respective intervals. This iterative approach is needed because the model (1)- (23) is quite sensitive to some of the model parameters, and is difficult to integrate numerically when the model parameter values are too far from those in the previous stage. For the purpose of model matching, we consider three possible objectives and solve the resulting parameter estimation problem with MISER 3.3. Table 3 . Lower and upper bounds for V , U b , U 0 , and β 3.1. Case 1. In this case, our aim is to match the simulated blood glucose level to the experimental data g exp (t) over the entire time horizon. Thus, the aim is to minimize
subject to the dynamic model defined by equations (1)-(23). The glucose trajectory generated from (1)-(23) using the optimal parameter estimates is shown in Figure 4 . Looking at Figures 3 and 4 , it is clear that the optimal parameter estimates yield significant improvements in model accuracy compared with the estimates in [8] . However, there appears to be some mismatch between the model trajectory and experimental data at the terminal time. Hence, we consider a modified version of the objective function (24) in the next case. 3.2. Case 2. Here, we add another term to the objective function that measures the difference between the predicted and actual blood glucose levels at the terminal time. Specifically, the aim is to minimize
subject to the dynamics (1)- (23), where the weight w is chosen as w = 1000. The idea here is to force better agreement between the model output and the experimental data at the end of the time horizon. As seen from Figure 5 , this can be achieved at the expense of increased error earlier in the time horizon.
3.3. Case 3. Since the experimental data in Table 2 is only measured at a small number of isolated times, the actual glucose level between these times is unknown. Thus, our definition of g exp (t), as a piecewise linear interpolating function, and the use of the integral terms in (24) and (25), may not be appropriate. An alternative parameter estimation problem is to minimize
subject to the dynamics (1)- (23), wherex i 8 and τ i , i = 1, . . . 9, are as defined in Table 2 . Note that this objective function is not in the standard canonical form due to the presence of multiple non-integral terms that depend on the state at Figure 5 . Comparison of two blood glucose trajectories: the solid trajectory is the simulated trajectory from (1)-(23) using the optimal parameter values for Case 2; the dashed trajectory is the experimental data from Korach-André et al. [5] intermediate times (called characteristic times in the optimal control literature). Nevertheless, objective functions of this form can be handled using the techniques developed in [9] and [11] , which have been incorporated into the MISER 3.3 software [4] . As shown in Figure 6 , the resulting blood glucose level tracks the individual experimental measurements very closely, although as expected it does not follow the interpolating function g exp (t) as closely as we observed for Case 1.
4. Model sensitivity. The optimal parameter values for Cases 1, 2 and 3 are reported in Table 4 . In Liu and Tang [8] , a sensitivity test was performed by doubling and halving the insulin feedback rate and observing the corresponding model response. For comparison, we perform the same sensitivity test on the model with the optimized parameters from Case 1. This involves replacing the original insulin feedback rate w 2 in (4) by
and
respectively. The resulting blood glucose levels are shown in Figures 7 and 8 Figure 6 . Comparison of two blood glucose trajectories: the solid trajectory is the simulated trajectory from (1)-(23) using the optimal parameter values for Case 3; the dashed trajectory is the experimental data from Korach-André et al. [5] levels in Figures 7 and 8 are further away from the experimental measurements. This is expected, since optimizing the model parameters will generally lead to a more sensitive model.
5.
Optimal insulin and glucose release rates. The feedback controls (2) and (4) model the physiology of the pancreas. Liu and Tang [8] have suggested that these natural feedback controls may not be "optimal" in the sense of regulating the blood glucose level. However, they did not check this conclusively by solving the associated optimal control problem [8] . In this section, we demonstrate that the optimal open loop controls for the insulin and glucose release rates can be readily calculated using the MISER 3.3 software [4] . We replace the closed loop controls w 1 and w 2 by corresponding open loop controls u 1 and u 2 , respectively. Thus, equations (1) and (3) become, respectively,
We assume that both u 1 and u 2 are parameterized as piecewise linear continuous functions in accordance with the control parameterization method [7, 12] . The objective function (adopted from the suggestion in [8] ) is given by:
This objective function penalizes both control effort and blood glucose deviation from the initial level. The problem is to minimize (30) subject to the dynamic model (1)-(23) with the optimized parameters from Case 1 (and with (1) and (3) replaced by (28) and (29)). As the model is quite sensitive to changes in u 1 and u 2 , we use a homotopy approach with the initial guesses of u 1 and u 2 as w 1 and w 2 (from the Case 1 optimized model), respectively. We initially imposed tight lower and upper bounds on u 1 and u 2 around the initial guesses. These bounds were then slowly relaxed over a series of optimization iterations until no more improvement in the objective was observed.
The optimal blood glucose trajectory is shown in Figure 9 and the optimal controls are shown in Figures 10 and 11 . As can be seen from Figure 9 , the blood glucose level corresponding to the optimal open loop controls remains very close to the initial blood glucose level (918 mg/l= 5.1 mmol/l) over the entire time horizon. This clearly demonstrates that excellent glucose control is achievable with the open loop formulation. However, the blood glucose response is quite different from that observed in experimental results. This raises the question of why the blood glucose regulatory system in the human body does not follow the 'optimal' approach calculated via the open loop formulation. One should note that the glucose regulatory system forms only one part of a more complex metabolic system that controls the human body. There are probably sound reasons why elevated blood glucose levels Figure 11 . The optimal insulin release rate. occur in humans after the ingestion of a meal, but these are not reflected in the glucose regulatory model considered here.
6. Conclusions. We have solved a complex model matching problem in which a glucose regulatory model must be fitted to experimental data to minimize total error. We investigated several different model matching objectives and found that significant improvement in matching the model to experimental data was achieved in all cases when compared to the results in Liu and Tang [8] . As expected, we also found that the optimized model was more sensitive to changes in the insulin release rate. Finally, we showed that open loop optimal controls can be readily calculated for the glucose regulatory system. However, the resulting glucose profiles no longer match real profiles observed experimentally, which suggests that more comprehensive models of the human body metabolism are needed.
Future work will consider the implementation of the glucose regulatory model for diabetic individuals and how their conditions can be controlled optimally.
